Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4241)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2024 (publication date) through May 20, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Lu SH, Yu YF, Dai SS, Hu YQ, Liu JH. Efficacy and safety of Yangxinshi tablet for chronic heart failure: A systematic review and meta-analysis. World J Clin Cases 2024; 12(13): 2218-2230 [PMID: 38808352 DOI: 10.12998/wjcc.v12.i13.2218] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Lu SH, Yu YF, Dai SS, Hu YQ, Liu JH. Efficacy and safety of Yangxinshi tablet for chronic heart failure: A systematic review and meta-analysis. World J Clin Cases 2024; 12(13): 2218-2230 [PMID: 38808352 DOI: 10.12998/wjcc.v12.i13.2218] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i13/2218.htm |
| Number | Citing Articles |
| 1 |
Jingwen Guo, Rong Miao, Qingying Fan, Yilin Li, Yuhua Tian, Aomei Sun, Qingrui Zhang, Zhenguo Lv, Guangwei Qi, Opoku Bonsu Francis, Rui Liu, Ting Chen, Qin Liu, Ruiqiao Li, Jun He, Yan Sun, Ling Leng, Miaomiao Jiang, Qilong Wang. Yangxinshi Tablet protects against post-myocardial infarction heart failure with reduced ejection fraction by improving energy metabolism through inhibition of FOXO1/PDK4 signaling. Chinese Journal of Natural Medicines 2026; 24(5): 574 doi: 10.1016/S1875-5364(26)61119-3
|
| 2 |
Binmei Zhang, Jingxiu Hou, Li Dong, Man Sun, Ying Dong, Yumei Dong. Administration with Yangxinshi ameliorates the progression of atrial fibrillation by affecting atrial remodeling and oxidative stress via the activation of the PI3K/AKT signaling. Cytotechnology 2025; 77(3) doi: 10.1007/s10616-025-00778-8
|